Geode Capital Management, LLC Lexicon Pharmaceuticals, Inc. Transaction History
Geode Capital Management, LLC
- $1.26 Trillion
- Q4 2024
A detailed history of Geode Capital Management, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 3,521,255 shares of LXRX stock, worth $2.61 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,521,255
Previous 3,523,971
0.08%
Holding current value
$2.61 Million
Previous $5.53 Million
52.91%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding LXRX
# of Institutions
134Shares Held
239MCall Options Held
459KPut Options Held
133K-
Artal Group S.A. Luxembourg, N4136MShares$101 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$28.8 Million3.05% of portfolio
-
Orbimed Advisors LLC San Diego, CA11MShares$8.16 Million0.41% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$7.32 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.88MShares$7.31 Million0.0% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $140M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...